» Articles » PMID: 7049802

Studies of Retinopathy and the Plasma Co-factor of Platelet Hyperaggregation in Type 1 (insulin-dependent) Diabetic Children

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1982 Jun 1
PMID 7049802
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Only one out of 73 children with young-onset Type 1 (insulin-dependent) diabetes for less than 10 years had retinopathy detectable with fluorescein retinal angiography. Although these fluorescent studies were normal, retinal abnormalities were detected in 19 out of 53 patients by electro-retinography and in four out of 28 patients by the 100-hue colour test. We were unable to confirm recent reports indicating that most Type 1 diabetic patients have retinopathy detectable by fluorescein angiography. The diabetic plasma co-factor induces normal platelets to hyperaggregate in vitro. Plasma co-factor activities in adult diabetic patients have previously been shown to correlate with the degree of hyperaggregation, although in general, only those patients with severe retinopathy or nephropathy have high plasma activities. The plasma activities of 192 Type 1 diabetic patients were significantly higher than those of normal subjects (p less than 0.01). Of ten children with markedly elevated activities, nine did not have retinopathy.

Citing Articles

Investigation of the Protective Effects of Taurine against Alloxan-Induced Diabetic Retinal Changes via Electroretinogram and Retinal Histology with New Zealand White Rabbits.

Chiang S, Yeh S, Chen Y, Lin S, Tseng J Int J Endocrinol. 2014; 2014:631549.

PMID: 25298779 PMC: 4178915. DOI: 10.1155/2014/631549.


Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Samuels I, Lee C, Petrash J, Peachey N, Kern T Vis Neurosci. 2012; 29(6):267-74.

PMID: 23101909 PMC: 3745719. DOI: 10.1017/S0952523812000326.


A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Bearse Jr M, Adams A, Han Y, Schneck M, Ng J, Bronson-Castain K Prog Retin Eye Res. 2006; 25(5):425-48.

PMID: 16949855 PMC: 2773701. DOI: 10.1016/j.preteyeres.2006.07.001.


Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Ladik T, Smolka B, Bock T, Schramm W, Spannagl M, Landgraf R Klin Wochenschr. 1987; 65(13):600-6.

PMID: 3626428 DOI: 10.1007/BF01726667.


Can retinopathy be prevented?.

Weber B, Hovener G, Burger W, Hartmann R, ENDERS I Indian J Pediatr. 1989; 56 Suppl 1:S99-107.

PMID: 2700570 DOI: 10.1007/BF02776473.

References
1.
Colwell J, Halushka P, Sarji K, Lopes-Virella M, Sagel J . Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979; 139(2):225-30. View

2.
Fleischman A, Bierenbaum M, Stier A, Somol H, Watson P . In vivo platelet function in diabetes mellitus. Thromb Res. 1976; 9(5):467-71. DOI: 10.1016/0049-3848(76)90202-4. View

3.
BARTA L, BROOSER G, Molnar M . [Diagnostic importance of fluorescein angiography in infantile diabetes]. Acta Diabetol Lat. 1972; 9(2):290-8. DOI: 10.1007/BF01564553. View

4.
Kinnear P, Aspinall P, LAKOWSKI R . The diabetic eye and colour vision. Trans Ophthalmol Soc U K (1962). 1972; 92:69-78. View

5.
Paetkau M, Boyd T, Winship B, Grace M . Cigarette smoking and diabetic retinopathy. Diabetes. 1977; 26(1):46-9. DOI: 10.2337/diab.26.1.46. View